Low dose naltrexone (LDN) shows promise in treating autoimmune diseases and cancers. Dr. Stephanie Werner shares insights on LDN's effectiveness in managing inflammation and enhancing patient outcomes, particularly in women's health issues like polycystic ovary syndrome and pregnancy challenges. The importance of diet and avoiding inflammatory foods is discussed, along with personal responsibility in healthcare and LDN's potential in managing chronic conditions.